These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15104647)

  • 1. Consensus conference on vCJD screening of blood donors: report of the panel.
    McCullough J; Anderson D; Brookie D; Bouchard JP; Fergusson D; Joly J; Kenny N; Lee D; Megânn H; Page D; Reinharz D; Williams JR; Wilson K
    Transfusion; 2004 May; 44(5):675-83. PubMed ID: 15104647
    [No Abstract]   [Full Text] [Related]  

  • 2. Should deceased donors be tested for vCJD?
    Warwick RM; Eglin R
    Cell Tissue Bank; 2005; 6(4):263-70. PubMed ID: 16308765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of vCJD on blood supply.
    Seitz R; von Auer F; Blümel J; Burger R; Buschmann A; Dietz K; Heiden M; Hitzler WE; Klamm H; Kreil T; Kretzschmar H; Nübling M; Offergeld R; Pauli G; Schottstedt V; Volkers P; Zerr I
    Biologicals; 2007 Apr; 35(2):79-97. PubMed ID: 17320412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood donors and vCJD].
    Grandjean P
    Ugeskr Laeger; 2001 Sep; 163(39):5389-90. PubMed ID: 11590962
    [No Abstract]   [Full Text] [Related]  

  • 5. The application of the precautionary principle to the blood system: the Canadian blood system's vCJD donor deferral policy.
    Wilson K; Wilson M; Hébert PC; Graham I
    Transfus Med Rev; 2003 Apr; 17(2):89-94. PubMed ID: 12733102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New variant Creutzfeldt-Jakob disease: a controversial but potential blood transfusion risk.
    Basu A
    Nepal Med Coll J; 2003 Jun; 5(1):51-2. PubMed ID: 16583978
    [No Abstract]   [Full Text] [Related]  

  • 7. Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples.
    Guntz P; Walter C; Schosseler P; Morel P; Coste J; Cazenave JP
    Transfusion; 2010 May; 50(5):989-95. PubMed ID: 20088835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion transmission of human prion diseases.
    Zou S; Fang CT; Schonberger LB
    Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.
    Dorsey K; Zou S; Schonberger LB; Sullivan M; Kessler D; Notari E; Fang CT; Dodd RY
    Transfusion; 2009 May; 49(5):977-84. PubMed ID: 19170987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of blood donors with a low level of exposure to vCJD.
    Pasqualetti D; Ghirardini A; Bellocco R; Vaglio S; Gozzer M; Girelli G
    Haematologica; 2001 Mar; 86(3):E04. PubMed ID: 11255291
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood-transmitted prions and variant Creutzfeldt-Jakob disease.
    Grady GF; Vyas GN
    Biologicals; 2007 Apr; 35(2):75-7. PubMed ID: 17317213
    [No Abstract]   [Full Text] [Related]  

  • 12. Variant Creutzfeldt-Jacob disease - the availability of a screening test will be the beginning, not the end, of difficult transfusion-related issues.
    Sandler SG
    Curr Opin Hematol; 2006 Nov; 13(6):445-6. PubMed ID: 17053456
    [No Abstract]   [Full Text] [Related]  

  • 13. New variant Creutzfeldt-Jakob disease and the blood supply: is it time to face the music?
    Hoey J; Giulivi A; Todkill AM
    CMAJ; 1998 Sep; 159(6):669-70. PubMed ID: 9780967
    [No Abstract]   [Full Text] [Related]  

  • 14. Progress towards a blood test for vCJD?
    Anstee DJ
    Vox Sang; 2002 Aug; 83 Suppl 1():203-5. PubMed ID: 12617138
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood transfusion linked to vCJD death.
    Bonn D
    Lancet Infect Dis; 2004 Feb; 4(2):65. PubMed ID: 14959755
    [No Abstract]   [Full Text] [Related]  

  • 16. Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion.
    Minor PD
    Vox Sang; 2004 Apr; 86(3):164-70. PubMed ID: 15078250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML; Ludlam CA
    Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creutzfeldt-Jakob disease.
    Oney D
    Pulse; 1999; 36(2):22. PubMed ID: 10614475
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfusion-related vCJD: prevention strategies for prion transmission.
    Holland PV
    Lijec Vjesn; 2007 May; 129 Suppl 3():46. PubMed ID: 18959066
    [No Abstract]   [Full Text] [Related]  

  • 20. Experts call for research into vCJD test despite only 70% accuracy.
    O'Dowd A
    BMJ; 2014 Feb; 348():g1415. PubMed ID: 24502931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.